Robyn Goforth, PhD

Robyn Goforth, PhD
As Vice President Technology Assessment at VIC, Dr. Goforth leads technical and commercial evaluation of technologies ranging from medical devices to pharmaceuticals as well as scientific research tools and instrumentation. Dr. Goforth also serves as Chief Scientific Officer of VIC portfolio company, BiologicsMD ™

Recent Posts

Behind the Curtain: Opportunity Assessment at VIC

Ask ten people how best to assess the value of a new technology, and you’ll likely get ten different answers. Google "opportunity assessment", and you will find hundreds of different templates, worksheets, and...

FEATURED RESOURCES

Updates
VIC 2021 Annual Report Executive Summary
Insight
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside UCSF Innovation Ventures with Executive Director, Anthony Francis
Insight
Protecting Early Investors in Capital-Intensive Life Science Companies
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
Interview
VIC Fellows Spotlight: Kelly Mabry, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission